Algernon NeuroScience Initiates Traumatic Brain Injury Research Program With DMT; Appoints Global TBI Expert as Advisor
21 févr. 2023 07h00 HE
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical...
ADM Diagnostics, Inc. Awarded $1.96 Million Grant From the National Institutes of Health
27 sept. 2022 09h00 HE
|
ADM Diagnostics Inc
NORTHBROOK, Ill., Sept. 27, 2022 (GLOBE NEWSWIRE) -- ADM Diagnostics, Inc. (ADMdx) has been awarded a two-year $1.96 million Phase II Small Business Innovation Research (SBIR) grant from the...
Study: Improvements in TBI Patients with Persistent Brain Fog
16 mai 2022 07h58 HE
|
Posit Science
SAN FRANCISCO, May 16, 2022 (GLOBE NEWSWIRE) -- A new study has shown that plasticity-based brain training can drive improvements in patients with persistent symptoms from Traumatic Brain Injury...
Worldwide Neurorehabilitation Industry to 2030 - Rising Demand of Telerehabilitation Presents Opportunities
17 févr. 2022 05h43 HE
|
Research and Markets
Dublin, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The "Neurorehabilitation Market by Type, Application, and End-User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...
The Worldwide Neurology Patient Monitoring Industry is Expected to Reach $7.4 Billion by 2030
26 janv. 2022 07h43 HE
|
Research and Markets
Dublin, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The "Neurology Patient Monitoring Market Size, Share & Trends Analysis Report by Application (Trauma, CSF Management, Migraine, Stroke, Hydrocephalus,...
Dr. David Margulies and Dr. Hal C. Lewis Present HEALING and REGENERATING the INJURED BRAIN
19 janv. 2022 14h00 HE
|
The Dan Lewis Foundation for Brain Regeneration Research
DENVER, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Talks at Google, a global talk series, recently presented Healing and Regenerating the Injured Brain with Dr. Hal Lewis and Dr. David Margulies. Drs. Lewis...
Neurological Biomarkers Market by Application, by Type, by End-use, by Region and Forecasts to 2028
06 déc. 2021 06h58 HE
|
Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer's, Parkinson's), By Type (Genomic, Proteomic), By...
Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device
19 oct. 2021 10h03 HE
|
Odyssey Group International
IRVINE, CA, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving...
The Importance of Testing for Traumatic Brain Injuries Before It's Too Late
06 oct. 2021 11h30 HE
|
Cambre & Associates
ATLANTA, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Traumatic brain injury (TBI) results from an impact to the head. Injuries can be mild or more serious and leave bruising, torn tissue, internal/external...
Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion
22 sept. 2021 08h39 HE
|
Odyssey Group International
IRVINE, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical company focused on developing unique, life-saving medical...